Source:http://linkedlifedata.com/resource/pubmed/id/14524644
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2003-10-3
|
pubmed:abstractText |
To investigate the relative numbers and clinical characteristics of pancreatitis in patients treated with the atypical antipsychotic agents, clozapine, olanzapine, and risperidone, versus the conventional neuroleptic, haloperidol.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0277-0008
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1123-30
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:14524644-Adverse Drug Reaction Reporting Systems,
pubmed-meshheading:14524644-Aged,
pubmed-meshheading:14524644-Antipsychotic Agents,
pubmed-meshheading:14524644-Humans,
pubmed-meshheading:14524644-Pancreatitis,
pubmed-meshheading:14524644-United States,
pubmed-meshheading:14524644-United States Food and Drug Administration
|
pubmed:year |
2003
|
pubmed:articleTitle |
Pancreatitis associated with atypical antipsychotics: from the Food and Drug Administration's MedWatch surveillance system and published reports.
|
pubmed:affiliation |
Division of Metabolic and Endocrine Drug Products, Center for Drug Evaluation and Review, Food and Drug Administration, Rockville, Maryland, USA.
|
pubmed:publicationType |
Journal Article,
Review
|